Abstract
Anti-IL-4/13 therapies, guided by knowledge of an individual's underlying pathophysiology, are a promising class of therapies for treatment of asthma.
Original language | English |
---|---|
Pages (from-to) | 570-575 |
Number of pages | 6 |
Journal | Current opinion in allergy and clinical immunology |
Volume | 14 |
Issue number | 6 |
DOIs | |
State | Published - 2014 |
Keywords
- Asthma
- IL-13
- IL-4
- Monoclonal antibody